SPARCL1 and breast neoplasm: In naive and breast tumor‐bearing immunocompetent mice, FTY720/Fingolimod that targets S1PR1, suppressed paclitaxel‐induced neuropathic pain, astrocyte activation, the astrocyte‐secreted synaptogenic protein Sparcl1/Hevin and synapse formation.